Some diabetes medicines can push blood sugar too low when carbohydrate intake drops, so ask your prescriber before changing how you eat. Confusion, seizures, fainting or unresponsiveness, or vomiting with rapid breathing, severe abdominal pain, drowsiness and fruity smelling breath, all need emergency care, call 911.
A lower-carbohydrate way of eating is any pattern that deliberately reduces the starches and sugars in the diet and lets protein, fat and non-starchy vegetables take up the space. That is a spectrum rather than a single diet, which is why two people can both say they eat low carb and be doing very different things at the dinner table.
The strictest end is the very low carbohydrate or ketogenic pattern, where carbohydrate drops far enough that the body shifts toward burning fat and producing ketones for fuel. The gentlest end is cutting added sugar while most meals stay intact. The labels matter when you read about outcomes, because different definitions sit behind the same two words.
| Pattern | What it generally looks like | How strict |
|---|---|---|
| Lower added sugar | Sugar sweetened drinks, sweets and refined baked goods reduced, most other foods unchanged | Least strict |
| Moderate carbohydrate reduction | Refined grains and starchy sides reduced, protein, fat and non-starchy vegetables take their place | Moderate |
| Low carbohydrate | Grains, starchy vegetables and sugars reduced across most meals | Strict |
| Very low carbohydrate (ketogenic) | Carbohydrate reduced far enough to shift fuel use toward fat and ketones | Strictest |
This page gives no gram targets and no meal plans, on purpose. The right level of restriction depends on medicines, kidney function, activity, appetite and what a person can sustain for years rather than weeks, and that is a conversation with a clinician or a registered dietitian rather than a number pulled off a web page. Studies indicate that carbohydrate restriction lowers blood glucose in people with type 2 diabetes and can serve as a first dietary step in diabetes management 2.
Hemoglobin A1C measures the percentage of haemoglobin inside red blood cells that has glucose chemically attached to it, which tracks average blood glucose over roughly the previous three months. It is a standard blood draw and does not require fasting. Labs typically regard 4 to 5.7 % as the reference range for adults. FitScript's optimal range is 4.6 to 5.3 %, an optimization target rather than a diagnostic cut-off. Reference ranges vary by lab, age and sex, and conditions that change red blood cell turnover can distort the number, so a result is read next to fasting glucose and symptoms rather than alone. The biomarker page linked above covers the test method, each band and what one result can and cannot show.
Carbohydrate is the macronutrient that becomes blood glucose fastest, so reducing it reduces the glucose the body has to clear after every meal. Protein and fat raise blood glucose far less, and far more slowly.
In people with type 2 diabetes, muscle and liver cells respond poorly to insulin and the pancreas compensates by releasing more of it. Glucose therefore lingers in the blood after eating, and the pancreas spends the day working against a load it cannot fully clear. A smaller carbohydrate load at a meal means a smaller rise to deal with, which flattens post-meal peaks and pulls down the daily average.
That average is exactly what the A1c test captures. Glucose attaches to haemoglobin in proportion to how much of it is circulating, so a lower average across weeks shows up as a lower percentage months later. Research suggests that the blood glucose response to carbohydrate restriction can appear before much weight has been lost, which is why some people notice home glucose readings changing within days 2.
There is a practical consequence. When the glucose load drops quickly while medicines stay the same, readings can fall further than intended. That is the single most important reason to speak with your prescriber first, because the dose that suited a higher carbohydrate intake may not suit a lower one, and only the prescriber can judge that.
A1c reflects average glucose, so when the glucose load from food falls and stays lower, the A1c measured months later moves with it. Research suggests that, at six months, low and very low carbohydrate diets produced greater reductions in A1c and higher rates of diabetes remission than control diets, with the difference smaller by twelve months 1.
The same direction shows up in narrower slices of the question. A systematic review and meta-analysis of randomized trials of very low carbohydrate (ketogenic) diets in type 2 diabetes reported reductions in A1c compared with control diets 4. A review of ketogenic eating in type 2 diabetes reported improvements in glycaemic control alongside weight loss 3. In a randomized trial comparing a very low carbohydrate pattern with a DASH pattern in adults with high blood pressure and prediabetes or type 2 diabetes, the very low carbohydrate group had the larger reduction in A1c 5.
Two caveats keep this honest. Average results hide wide individual variation, so a group effect is not a personal prediction. And because the test looks backward over about three months, rechecking two weeks after a diet change tells you almost nothing. A clinician decides when a repeat draw is informative, usually once enough time has passed for new red blood cells to carry the new average.
If an A1c result sits above the standard range, that is suboptimal rather than a verdict, and it is worth discussing with a clinician who can look at it next to fasting glucose, medicines and symptoms.
Remission means blood glucose stays in the non-diabetic range without glucose lowering medicines, judged over time by a clinician, and it is a real outcome for some people rather than a permanent state for everyone. Research suggests that, at six months, low and very low carbohydrate diets achieved higher remission rates than control diets, with that advantage largely gone by twelve months in the pooled trial data 1.
That pattern of early gain and later fade is the most useful thing to take from the remission question. It tells you the physiology responds, and it tells you that adherence over the long run, not the first enthusiastic month, is what decides where someone lands.
Remission also does not mean the underlying tendency has gone. Insulin resistance can return when the eating pattern returns, and glucose follows. Monitoring continues either way, and the decision to change or stop any medicine belongs to the prescriber, never to the person reading a lab report at home.
If a result improves enough that remission is on the table, that is a conversation to have with a clinician rather than a conclusion to reach alone. Treatment decisions belong to a licensed provider.
Weight usually moves down alongside A1c on lower-carbohydrate eating, partly because protein and fat are more filling per meal and partly because whole food categories leave the diet. Research suggests that low and very low carbohydrate diets produced greater weight loss than control diets at six months 1.
A meta-analysis of randomized trials of very low carbohydrate (ketogenic) diets in type 2 diabetes reported reductions in body weight compared with control diets 4, and the trial comparing a very low carbohydrate pattern with a DASH pattern reported greater weight loss in the very low carbohydrate group 5.
Why weight matters here is mechanical. Fat stored in the liver and around the organs is closely tied to how well insulin works, so losing it tends to improve the glucose picture beyond the direct effect of eating less starch. That is also why two people with the same A1c change can have very different body composition stories underneath.
Scale weight alone is a blunt instrument. Waist measurement, strength, and how clothes fit track the useful part of the change better than a single morning number, because muscle and water shift early on a lower-carbohydrate pattern. If weight falls fast and unintentionally, or keeps falling without explanation, that is worth discussing with a clinician promptly.
Lipids do not all move in the same direction on a lower-carbohydrate diet, which is the main reason a lipid panel belongs in the follow-up plan. Studies suggest that very low carbohydrate ketogenic eating in people with type 2 diabetes lowers triglycerides and raises HDL cholesterol, while total and LDL cholesterol responses vary between people 6.
The triglyceride effect is the most consistent part. Triglycerides respond strongly to carbohydrate intake, especially refined starch and sugar, so cutting those tends to pull the number down. HDL often drifts up over the same period. LDL cholesterol is the part that can surprise people, because it rises in some individuals on higher fat intakes and falls in others. A meta-analysis of very low carbohydrate trials in type 2 diabetes found glycaemic and triglyceride improvements with less consistency in LDL cholesterol 4.
This is why one panel at one point in time is not enough to judge the approach. The sensible reading is observation, then meaning, then next step. The observation is the direction each lipid moved. The possible meaning depends on which lipids changed and by how much, together with family history and other cardiovascular markers. The next step is a clinician reviewing the whole panel, often including apolipoprotein B, rather than reacting to a single LDL value.
If LDL cholesterol or apolipoprotein B rises substantially after a dietary change, that is worth raising with a clinician promptly rather than waiting for the next annual draw.
Liver fat is part of the same metabolic picture as blood glucose, and it responds to carbohydrate intake. A randomized trial comparing a calorie unrestricted low carbohydrate, high fat diet with a high carbohydrate, low fat diet in people with type 2 diabetes and non-alcoholic fatty liver disease reported greater reductions in A1c and in liver fat content on the low carbohydrate pattern 7.
The link runs through the liver's handling of sugar. Excess fructose and refined starch give the liver more raw material for making fat, and fat accumulating inside liver cells is associated with poorer insulin sensitivity. Lowering the supply of that raw material reduces the pressure in one step, which is why liver enzymes and liver imaging sometimes improve alongside glucose markers.
For someone whose blood work already shows a raised ALT or GGT without another explanation, this is a reason to look at the liver as part of the same conversation rather than as a separate problem. Fatty liver is common in people with type 2 diabetes and is frequently silent, meaning the first sign is often a lab value rather than a symptom.
None of that makes the liver picture self-managed. An abnormal liver enzyme has many possible explanations, including some medicines, alcohol intake and viral causes, and sorting between them is a clinician's job.
The table below summarises what cited comparisons reported, not what any pattern will do for an individual.
| Eating pattern | Core idea | What a cited comparison reported |
|---|---|---|
| Very low carbohydrate (ketogenic) | Carbohydrate restricted far enough to shift fuel use toward fat and ketones | Compared with a DASH pattern in adults with high blood pressure and prediabetes or type 2 diabetes, greater reductions in A1c and body weight were reported in the very low carbohydrate group 5 |
| DASH | Vegetables, fruit, whole grains, lower fat dairy and reduced sodium | Used as the active comparator in the same randomized trial, with smaller A1c and weight change than the very low carbohydrate arm 5 |
| Low carbohydrate, high fat (calorie unrestricted) | Carbohydrate reduced without counting calories, fat intake higher | Compared with a high carbohydrate, low fat diet in people with type 2 diabetes and fatty liver, greater reductions in A1c and liver fat were reported 7 |
| High carbohydrate, low fat | Fat reduced, carbohydrate forms the bulk of energy intake | Served as the comparator in that trial, with smaller changes in A1c and liver fat 7 |
The honest summary is that lower-carbohydrate patterns tend to win on short to medium term glucose and weight outcomes in these comparisons, while the patterns they are compared against have their own long records for blood pressure and cardiovascular outcomes. The pattern a person can hold onto is the one that keeps working, and a clinician or dietitian is better placed than an average to judge which that is.
A systematic review and meta-analysis of long-term low carbohydrate diets in people with type 2 diabetes reported improvements in glycaemic control and weight that were modest over extended follow-up 8, and the pooled trial data on remission showed the advantage over control diets diminishing by twelve months 1.
The practical reading is not that the approach stops working. It is that the first six months tend to flatter it, and planning should assume the harder part comes later. People who do well long term usually settle at a level of restriction they can live with rather than the strictest version they started on, and they keep testing.
That makes repeat blood work the real feedback loop. A1c every few months, as decided by a clinician, plus a lipid panel and liver and kidney markers, shows whether the pattern is still delivering and whether anything else has shifted in the background.
A1c is a summary, so it is read alongside markers that show the mechanism and the side effects of a dietary change. Fasting glucose and fasting insulin together describe how hard the pancreas is working to hold that average, and the calculated HOMA-IR puts a number on insulin resistance that A1c alone cannot see.
A full lipid panel matters because of the varied cholesterol response, and apolipoprotein B gives a count of atherogenic particles that a standard LDL value can understate. The triglyceride to HDL ratio is a cheap extra read on metabolic health from numbers already on the panel.
Liver markers such as ALT, AST and GGT track the liver fat question. Kidney markers, including creatinine, eGFR and urine albumin to creatinine ratio, matter because kidney function shapes what level of protein and what medicines are appropriate. Uric acid and high sensitivity CRP round out the metabolic and inflammatory picture, and they sometimes move when eating patterns change substantially.
FitScript's membership includes 150+ biomarkers tested per year, with Atlas, its AI health advisor, interpreting the results against a member's own history rather than a single cut-off. Whatever the testing route, the value comes from repeating the same markers over time, because a trend says far more than one draw.
Carbohydrate concentrates in grains, starchy vegetables, sugars and most fruit, and it is minimal in meat, fish, eggs, oils and leafy vegetables. The table below groups common foods by relative carbohydrate content, with no amounts and no targets, because the useful skill is recognising where carbohydrate sits rather than counting it on a page.
| Food group | Examples | Relative carbohydrate content |
|---|---|---|
| Sugary drinks and sweets | Soft drinks, fruit juice, sweets, desserts | High |
| Refined grains and baked goods | White bread, pastries, white rice, pasta, crackers | High |
| Whole grains | Oats, barley, brown rice, wholegrain bread | High |
| Starchy vegetables | Potato, sweet potato, corn, peas | High to moderate |
| Dried and tropical fruit | Dates, raisins, banana, mango | High |
| Legumes | Beans, lentils, chickpeas | Moderate |
| Berries and lower sugar fruit | Strawberries, raspberries, blackberries | Moderate to low |
| Dairy | Sweetened yoghurt and milk moderate, plain yoghurt and cheese lower | Moderate to low |
| Nuts and seeds | Almonds, walnuts, pumpkin seeds | Low to moderate |
| Non-starchy vegetables | Leafy greens, broccoli, courgette, peppers, cauliflower | Low |
| Protein foods | Eggs, fish, poultry, meat, shellfish | Minimal |
| Fats and oils | Olive oil, butter, avocado | Minimal |
Two things hide carbohydrate from people who think they have cut it. Drinks, including juice and sweetened coffee, carry it without the sense of having eaten. Sauces, dressings, marinades and flavoured yoghurts carry added sugar that the label lists and the plate does not. This table is a map of where carbohydrate lives, not a prescription for any individual, and a clinician or registered dietitian can say what fits a particular situation.
Anyone taking diabetes medicines that can cause low blood sugar needs a prescriber involved before carbohydrate intake drops, because the same medicine against a smaller glucose load can take readings lower than intended. That conversation is the first step, not an optional extra, and this page is about type 2 diabetes only.
Several situations call for extra caution and a clinician's judgement. In people with reduced kidney function, protein and fluid considerations change what is appropriate. In people who are pregnant or planning pregnancy, nutritional needs differ and strict restriction is not a self-directed decision. In people with a history of disordered eating, rule heavy patterns can be destabilising. In people with type 1 diabetes, the physiology is different and the decisions belong entirely to the specialist care team.
The common practical problems are predictable. Fibre intake can fall when vegetables are cut alongside grains, which changes bowel habit. Early weeks can feel flat while the body adapts its fuel use. Saturated fat intake can climb if the carbohydrate removed is replaced mostly with processed meat and cheese, which matters more for some lipid profiles than others. And restriction that feels easy in month one can feel impossible in month eight, which is when results slip.
None of these is a reason to abandon the idea. They are the things worth naming in advance so the follow-up appointment has an agenda.
Before you start is the single most important time, specifically with whoever prescribes your medicines, because some medicines can cause lows when carbohydrate intake drops. After that, a few situations deserve a prompt conversation rather than a wait and see approach.
Repeated low blood sugar readings, dizziness, shakiness or confusion need prompt attention. Blood glucose readings that stay high despite a sustained dietary change deserve review, since the explanation may lie elsewhere. A substantial rise in LDL cholesterol or apolipoprotein B after a dietary change is worth discussing with a clinician promptly, as is a new or rising liver or kidney marker. Unintentional rapid weight loss, persistent vomiting, or a general sense of being unwell are all reasons to seek care rather than adjust the diet further.
The pattern that works is observation, meaning, next step. The observation is the lab value or the symptom. The possible meaning is a short list a clinician can narrow, not a conclusion from one number. The next step is a decision made with a licensed provider who has seen your full history, since treatment decisions belong to a licensed provider.
This article is educational and is not medical advice. Discuss your lab results and any change to how you eat with a clinician or licensed provider before you act on them.
For the step by step view of moving a single result, see how to lower your hemoglobin a1c. To understand why this page covers type 2 only, read type 1 vs type 2 diabetes. And if the terminology blurs together, is insulin resistance and diabetes the same separates the two ideas.
No. It suits many people, but kidney function, pregnancy, a history of disordered eating and the medicines you take all change the picture. Some diabetes medicines can cause blood sugar to drop too low when carbohydrate intake falls, so ask your prescriber before you change anything. A clinician decides what level of change is appropriate for your situation.
A1c reflects average blood glucose over roughly the previous three months, so a repeat test a couple of weeks after a diet change tells you very little. Home glucose readings move much sooner and give earlier feedback. Your clinician decides when a repeat draw is worth doing.
No. Low carbohydrate is a spectrum that runs from simply cutting added sugar through to very low carbohydrate or ketogenic eating. Most people who do well long term settle somewhere they can sustain rather than at the strictest end. Where you sit on that spectrum is best worked out with a clinician or a registered dietitian.
That is entirely a prescriber's decision. Lowering the carbohydrate load changes how much glucose your medicines are working against, which is why the conversation has to happen before you start rather than after a low reading. Never adjust or stop a medicine on your own based on a lab result or a home glucose reading.
A ketogenic diet is the strictest end of the low carbohydrate spectrum, restrictive enough that the body shifts toward burning fat and producing ketones. All ketogenic diets are low carbohydrate, but plenty of low carbohydrate eating is nowhere near ketogenic. The two are not interchangeable when you read about outcomes.
Remission means blood glucose stays in the non-diabetic range without glucose lowering medicines, confirmed over time by a clinician. It is not the same as the condition having permanently gone, since glucose can rise again if the eating pattern changes. Monitoring continues either way, and only a clinician can say whether a result meets the definition.
This page covers type 2 diabetes only. Type 1 involves different physiology and different risks around insulin and ketones, and dietary decisions there belong to the specialist care team. Anyone with type 1 should raise the question with their own clinicians rather than applying type 2 guidance.
Fasting glucose and fasting insulin show how hard the pancreas is working to hold that average, and a full lipid panel with apolipoprotein B shows the cholesterol side of the change. Liver markers such as ALT and GGT and kidney markers such as eGFR and urine albumin are also commonly checked. Your clinician decides which markers fit your history and how often to repeat them.